Sobi Exits Nirsevimab Cost-Sharing Pact With AstraZeneca, Simplifies Royalty Deal With Sanofi

 
• By Joseph Haas
  
Businessman sinking in heap of documents and asking for help
Sobi says new agreements simplify rights pertaining to nirsevimab

More from Deals

More from Business